Activity value 72china Buyer&Supplier,Last transaction date:
2026-07-20Address: 141 thomsom road,tai yip building - room 305,hong kong cn
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for universal pharmaceutical from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 7 transactions, with a transaction quantity of 296 and a transaction weight of 0.
Hs code
29321900
Product tags
bat,t 10,drum,pharm,empagliflozin,univer,shipment from china,powder form,expiry date,pharmaceutical raw material,bran,gh
Product description
PHARMACEUTICAL RAW MATERIAL ( EMPAGLIFLOZIN ) IN POWDER FORM ...BATCH NO EPG260102...MFG DATE 10.01.2026...EXPIRY ADTE 09.01.2028...BATCH NO EPG260103...MFG DFATE 15.01.2026..EXPIRY DATE 14.01.2028...QUANTITY 12 DRUM ...NET WEIGHT 100 KGS ...BRAND UNIVERSAL PHARMA ...I/O AND SHIPMENT FROM CHINA
Expand
universal pharmaceutical is china Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,bat,ertugliflozin.
According to the 52wmb.com global trade database, as of 2026-07-20, the company has completed 149 international trades,
with its main trading regions covering pakistan,india,united states etc.
The core products include HS29339990,HS29329990,HS29335990 etc,
often transported via mcc peshawar torkham exports,port rotterdam etc,
and its main trading partners are styrax pharma pvt ltd.,biocon,agp s.a.c..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on universal pharmaceutical is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.